![]()
|
|
||||||||
J Biol Chem, Vol. 273, Issue 7, 3895-3900, February 13, 1998
B and HIV-1 Long Terminal Repeat
Transcriptional Activation by Inducible Nitric Oxide Synthase 2 Activity
§,
From the In the human lymphoblastoid T cell line
JJhan-5.1, stably transfected with a human immunodeficiency virus-1
long terminal repeat luciferase vector, the level of luciferase
activity is dependent on activation of the nuclear factor
Unité 571 du CNRS,
Bâtiment 430, Université Paris-Sud, F-91405 Orsay Cedex
and § Unité de Biologie des Rétrovirus, Institut
Pasteur, 28 rue du Dr. Roux,
F-75724 Paris Cedex 15, France
B
(NF-
B) transcription factor. Tumor necrosis factor-induced
luciferase activity was not modified in JJhan-5.1 cells co-cultivated
with murine adenocarcinoma EMT-6 cells but was strongly decreased when
nitric oxide (NO) synthase 2 expression was induced in these cells. Two
NO synthase inhibitors counteracted this inhibitory effect. Tumor
necrosis factor-
binding to JJhan-5.1 cells was not modified after
incubation with EMT-6 cells. Viability and protein synthesis in
JJhan-5.1 cells were also unchanged. Induction of NF-
B DNA binding
activity was inhibited when EMT-6 cells expressed NO synthase 2 activity. Aminoguanidine, which completely abolished nitrite
production, prevented this inhibition. NF-
B activation was also
strongly inhibited by S-nitrosoglutathione but was
marginally affected by
N-(2-aminoethyl)-N-(2-hydroxy-2-nitrosohydrazino)-1,2-ethylenediamine. Taken together, these results indicated that NO-related species, released by EMT-6 effector cells and probably different from NO itself,
inhibited NF-
B activation in human lymphoblastoid target cells.
Consequently, transcriptional activity of a long terminal repeat-driven
luciferase gene construct was markedly diminished.
This article has been cited by other articles:
![]() |
J. Zhang, B. Peng, and X. Chen Expressions of Nuclear Factor {kappa}B, Inducible Nitric Oxide Synthase, and Vascular Endothelial Growth Factor in Adenoid Cystic Carcinoma of Salivary Glands: Correlations with the Angiogenesis and Clinical Outcome Clin. Cancer Res., October 15, 2005; 11(20): 7334 - 7343. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Blesson, J. Thiery, C. Gaudin, R. Stancou, J.-P. Kolb, J.-L. Moreau, J. Theze, F. Mami-Chouaib, and S. Chouaib Analysis of the mechanisms of human cytotoxic T lymphocyte response inhibition by NO Int. Immunol., October 1, 2002; 14(10): 1169 - 1178. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Dickie, A. Roberts, and R. Lee A defect in HIV-1 transgenic murine macrophages results in deficient nitric oxide production J. Leukoc. Biol., October 1, 2001; 70(4): 592 - 600. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Jiménez, J. González-Nicolás, S. Alvarez, M. Fresno, and M. A. Muñoz-Fernández Regulation of Human Immunodeficiency Virus Type 1 Replication in Human T Lymphocytes by Nitric Oxide J. Virol., May 15, 2001; 75(10): 4655 - 4663. [Abstract] [Full Text] |
||||
![]() |
U. Ponnappan and L. S. F. Soderberg Inflammatory macrophage nuclear factor-{kappa}B and proteasome activity are inhibited following exposure to inhaled isobutyl nitrite J. Leukoc. Biol., April 1, 2001; 69(4): 639 - 644. [Abstract] [Full Text] |
||||
![]() |
H. E. MARSHALL, K. MERCHANT, and J. S. STAMLER Nitrosation and oxidation in the regulation of gene expression FASEB J, October 1, 2000; 14(13): 1889 - 1900. [Abstract] [Full Text] |
||||
![]() |
B.L. Slomiany, J. Piotrowski, and A. Slomiany Effect of ebrotidine on Helicobacter pylori lipopolysaccharide-induced up-regulation of endothelin-1 in gastric mucosa Innate Immunity, October 1, 1999; 5(5-6): 279 - 285. [Abstract] [PDF] |
||||
![]() |
S. Glockzin, A. von Knethen, M. Scheffner, and B. Brune Activation of the Cell Death Program by Nitric Oxide Involves Inhibition of the Proteasome J. Biol. Chem., July 9, 1999; 274(28): 19581 - 19586. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Jilling, I. Y. Haddad, S. H. Cheng, and S. Matalon Nitric oxide inhibits heterologous CFTR expression in polarized epithelial cells Am J Physiol Lung Cell Mol Physiol, July 1, 1999; 277(1): L89 - L96. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Chen, Y. Lu, V. Castranova, Y. Rojanasakul, K. Miyahara, Y. Shizuta, V. Vallyathan, X. Shi, and L. M. Demers Nitric Oxide Inhibits HIV Tat-Induced NF-{kappa}B Activation Am. J. Pathol., July 1, 1999; 155(1): 275 - 284. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |